Co-Authors
This is a "connection" page, showing publications co-authored by Meletios Dimopoulos and Theodora Psaltopoulou.
Connection Strength
4.185
-
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19. Hemasphere. 2020 Jun; 4(3):e409.
Score: 0.883
-
Anthropometric characteristics, physical activity and risk of hematological malignancies: A systematic review and meta-analysis of cohort studies. Int J Cancer. 2019 07 15; 145(2):347-359.
Score: 0.809
-
Alcohol consumption and risk of hematological malignancies: A meta-analysis of prospective studies. Int J Cancer. 2018 08 01; 143(3):486-495.
Score: 0.761
-
Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit. Cancers (Basel). 2021 Feb 12; 13(4).
Score: 0.232
-
Emerging treatment strategies for COVID-19 infection. Clin Exp Med. 2021 May; 21(2):167-179.
Score: 0.228
-
Response of an oncology unit in the midst of the COVID-19 outbreak. J Oncol Pharm Pract. 2020 Dec; 26(8):1947-1952.
Score: 0.227
-
Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020 Nov; 20(4):493-506.
Score: 0.224
-
Hematological findings and complications of COVID-19. Am J Hematol. 2020 07; 95(7):834-847.
Score: 0.221
-
Meat, fish, dairy products and risk of hematological malignancies in adults - a systematic review and meta-analysis of prospective studies. Leuk Lymphoma. 2019 08; 60(8):1978-1990.
Score: 0.204
-
Consumption of fruits, vegetables, and risk of hematological malignancies: a systematic review and meta-analysis of prospective studies. Leuk Lymphoma. 2018 02; 59(2):434-447.
Score: 0.183
-
Early and late endocrine complications of COVID-19. Endocr Connect. 2021 Sep 20; 10(9):R229-R239.
Score: 0.061
-
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19. Thromb Haemost. 2020 Dec; 120(12):1680-1690.
Score: 0.057
-
Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: results of the prospective ROADMAP-MM-CAT study. Blood Cancer J. 2018 11 07; 8(11):102.
Score: 0.050
-
Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity. J Am Coll Cardiol. 2017 12 19; 70(24):3072.
Score: 0.047